Improved Outcomes with Linezolid for Methicillin-Resistant Staphylococcus aureus Infections: Better Drug or Reduced Vancomycin Susceptibility?
Open Access
- 1 November 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (11) , 4816-4817
- https://doi.org/10.1128/aac.49.11.4816-4817.2005
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Vancomycin-resistant staphylococci and enterococci: epidemiology and controlCurrent Opinion in Infectious Diseases, 2005
- Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue InfectionsAntimicrobial Agents and Chemotherapy, 2005
- Low-level vancomycin resistance in Staphylococcus aureus?an Australian perspectiveEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Treatment Outcomes for Serious Infections Caused by Methicillin‐ResistantStaphylococcus aureuswith Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2004
- Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin‐IntermediateStaphylococcus aureusClinical Infectious Diseases, 2004
- Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.2003
- Linezolid vs Vancomycin *Chest, 2003
- Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic MethodsAntimicrobial Agents and Chemotherapy, 2003
- The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus AureusAnnual Review of Microbiology, 2002
- Vancomycin-resistant Staphylococcus aureus : a new model of antibiotic resistanceThe Lancet Infectious Diseases, 2001